Amount Raised
$200 Million
Round Type
Post-IPO Equity
Salt Lake CityBiotechnologyHealthcareHealth CareArtificial IntelligenceTherapeuticsPharmaceuticalInvestors
Description
On October 15, 2026, Recursion Pharmaceuticals entered into an underwriting agreement to sell 61,540,000 shares of its Class A common stock at a price of $3.25 per share. The gross proceeds from this offering are expected to be approximately $200 million, before deductions. The offering is slated to close on October 16, 2026, pending customary closing conditions. This capital infusion will support Recursion's ongoing drug discovery efforts.
Who else raised in Healthcare and Therapeutics around the same time
Companies in the same sectors as Recursion Pharmaceuticals that raised within 45 days of this round, from Fundz verified event records.
- Pathos AI raised $237M (Series E) on October 23, 2026.
- Os Therapies raised $7.2M on October 15, 2026.
- Orakl Oncology raised $34M (Series A) on November 12, 2026.
- Neurosterix raised $105M (Series B) on November 11, 2026.
- Biograil raised $22M on November 4, 2026.
- Omabit raised $2M (Seed) on October 27, 2026.
Who to call at Recursion Pharmaceuticals, and when
A new round usually means Recursion Pharmaceuticals is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Recursion Pharmaceuticals raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Recursion Pharmaceuticals, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Recursion Pharmaceuticals. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Recursion Pharmaceuticals raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Recursion Pharmaceuticals raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.